AWA’s IP attorneys are experts in patents, trademarks, design, copyright and domain names—all as passionate about innovations and brands as you are. Founded in 1897 by the Swedish engineer Anders WilhelmAndersson, we bring over 125 years of experience to our clients.

AWA has one of Europe’s largest life science teams, with technical competence across multiple specialised fields. Their dedicated team provides clients with comprehensive, business-oriented advice and extensive legal, scientific, and industry-specific insights.

They tailor and scale their services to their client’s needs when supporting with e.g. patentability assessments, drafting and prosecuting patent applications, IP strategy, patent landscape analyses and monitoring, FTO analyses, due diligence, third party observations and oppositions.

They are dedicated to supporting the rapidly advancing ATMP sector and overcoming challenges in obtaining patent protection for cutting-edge ATMP technologies. With AWA’s combination of patent attorneys and attorneys at law by your side, they can establish legal frameworks and agreements, particularly for clinical trials and hospital exemptions.

Life science is a high-risk sector, and we work with you to provide guidance and support at every stage.

Feel free to contact AWA if you have any IP-related questions or are unsure whether and when to seek assistance.

We would be happy to meet with you in person at Flemingsberg or online for an initial discussion free of charge.

Joanna Applequist
Joanna.Applequist@awa.com
+46 73 802 71 73

Joanna is a partner and European Patent Attorney at AWA. She has over 13 years of experience of as an intellectual property advisor and works in close collaboration with clients and inventors. Her focus areas are biological and small molecule pharmaceuticals and formulation thereof, protein engineering, antibodies, immunology, vaccine development, cell and gene therapy (ATMPs), stem cells, and neurobiology.

Joanna is an experienced lecturer and provides expert patent analysis and commentary to leading industry publications on topics such as Crispr-Cas9 technology, patenting of ATMPs and due diligence analysis.

She has an M.Sc. in Engineering Biology and received her Ph.D. in Cell and Molecular Biology from the Karolinska Institute. Joanna has a profound understanding of developmental biology and neurobiology, including stem cells and cell differentiation from more than a decade of research experience.

Edit Szodorai
Edit.Szodorai@awa.com
+46 795 85 00 69

Edit supports clients mainly in the areas of biological and small-molecule pharmaceuticals and formulations, antibodies and protein engineering, vaccine development, cell and gene therapy (ATMPs), diagnostics as well as omics technologies.

She has ten years of research experience in neuroscience, proteomics and protein science, biochemistry, biophysics, molecular biology and biotech. She obtained her PhD in Neuroscience at the Medical University of Vienna in 2018 and worked as a postdoctoral researcher at the Karolinska Institute before joining AWA in 2021.

Joanna and Edit expect to be on-site at Innovation Station Flemingsberg on Thursdays every two weeks starting 12 September 2024 and on additional occasions.